Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
9.44
-0.34 (-3.48%)
At close: Jun 30, 2026, 4:00 PM EDT
9.59
+0.15 (1.59%)
After-hours: Jun 30, 2026, 7:04 PM EDT
Bioventus Market Cap
Bioventus has a market cap or net worth of $788.57 million as of June 30, 2026. Its market cap has increased by 77.10% in one year.
Market Cap
788.57M
Enterprise Value
1.04B
1-Year Change
77.10%
Ranking
Category
Stock Price
$9.44
Market Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has increased from $713.47M to $788.57M, an increase of 10.53%. That is a compound annual growth rate of 1.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 662.58M | 32.97% |
| Dec 31, 2025 | 498.30M | -27.40% |
| Dec 31, 2024 | 686.36M | 106.84% |
| Dec 29, 2023 | 331.83M | 105.22% |
| Dec 30, 2022 | 161.69M | -81.23% |
| Dec 31, 2021 | 861.26M | 20.71% |
| Feb 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lumexa Imaging Holdings | 1.08B |
| Tandem Diabetes Care | 1.05B |
| Artivion | 1.04B |
| CONMED | 975.84M |
| InMode | 933.59M |
| SS Innovations International | 736.48M |
| CeriBell | 736.09M |
| Beta Bionics | 727.25M |